- Home
- OII vs FOLD Comparison
OII vs FOLD Comparison
Compare OII & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OII
- FOLD
- Stock Information
- Founded
- OII 1964
- FOLD 2002
- Country
- OII United States
- FOLD United States
- Employees
- OII N/A
- FOLD N/A
- Industry
- OII Oilfield Services/Equipment
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- OII Energy
- FOLD Health Care
- Exchange
- OII Nasdaq
- FOLD Nasdaq
- Market Cap
- OII 2.7B
- FOLD 2.9B
- IPO Year
- OII N/A
- FOLD 2007
- Fundamental
- Price
- OII $22.53
- FOLD $9.19
- Analyst Decision
- OII Hold
- FOLD Strong Buy
- Analyst Count
- OII 5
- FOLD 9
- Target Price
- OII $28.20
- FOLD $17.00
- AVG Volume (30 Days)
- OII 688.2K
- FOLD 2.3M
- Earning Date
- OII 02-19-2025
- FOLD 02-19-2025
- Dividend Yield
- OII N/A
- FOLD N/A
- EPS Growth
- OII 51.58
- FOLD N/A
- EPS
- OII 1.44
- FOLD N/A
- Revenue
- OII $2,661,161,000.00
- FOLD $528,294,999.00
- Revenue This Year
- OII $9.79
- FOLD $34.88
- Revenue Next Year
- OII $6.95
- FOLD $20.78
- P/E Ratio
- OII $15.65
- FOLD N/A
- Revenue Growth
- OII 9.75
- FOLD 32.29
- 52 Week Low
- OII $19.68
- FOLD $8.79
- 52 Week High
- OII $30.98
- FOLD $14.02
- Technical
- Relative Strength Index (RSI)
- OII 30.03
- FOLD 38.52
- Support Level
- OII $24.69
- FOLD $9.32
- Resistance Level
- OII $26.11
- FOLD $10.00
- Average True Range (ATR)
- OII 0.89
- FOLD 0.33
- MACD
- OII -0.16
- FOLD -0.05
- Stochastic Oscillator
- OII 4.79
- FOLD 17.35
About OII Oceaneering International Inc.
Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.